Community
Pete Hegseth could make US history over impeachment threat
By Michelle Rivera
Ozempic, Wegovy and Zepbound get new FDA warning over rare condition
Michelle Rivera
Michelle Rivera
Reporter · Cleveland, OH
Michelle, an Ohio State University graduate, has spent over six years focusing on community issues in Cleveland, including social justice and local initiatives. She has previously written for NPR's local affiliates, where she honed her storytelling skills to highlight diverse community voices.
More from Michelle →Reporter · Tuesday, November 10, 2026 at 2:33 PM · 1 min read
People taking popular weight-loss and diabetes drugs are getting a new safety warning. The Food and Drug Administration is requiring all GLP-1 drugs to carry information about a potential increased risk of a rare eye condition that can cause permanent vision loss, according to the FDA’s Nov. 9 drug safety communication. The medications include Ozempic, Wegovy, Mounjaro and Zepbound.
Up nextPete Hegseth could make US history over impeachment threatCommunity · 1 min read
More Community stories
Community
Boris' Kosher Meat finds new owner after 43 years
By Michelle Rivera
Community
Cleveland’s Rory O’Malley returns to ‘The Book of Mormon’ on Broadway for limited run
By Michelle Rivera
Community
Voters approve tax increase for North Royalton Fire Department one day after loss of firefighter
By Michelle Rivera